SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 323 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.96 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $557,000 | +19.0% | 3,268 | -2.0% | 0.01% | 0.0% |
| Q3 2020 | $468,000 | -15.2% | 3,333 | -3.1% | 0.01% | -14.3% |
| Q2 2020 | $552,000 | +6.2% | 3,440 | -35.2% | 0.01% | -22.2% |
| Q1 2020 | $520,000 | +53.4% | 5,311 | +138.2% | 0.01% | +80.0% |
| Q2 2019 | $339,000 | +37.8% | 2,230 | +8.1% | 0.01% | +25.0% |
| Q1 2019 | $246,000 | +22.4% | 2,063 | +12.1% | 0.00% | 0.0% |
| Q4 2018 | $201,000 | -42.9% | 1,840 | -15.6% | 0.00% | -33.3% |
| Q3 2018 | $352,000 | +41.9% | 2,179 | +15.9% | 0.01% | +20.0% |
| Q2 2018 | $248,000 | +22.2% | 1,880 | -31.5% | 0.01% | +25.0% |
| Q1 2018 | $203,000 | -59.6% | 2,744 | -69.6% | 0.00% | -60.0% |
| Q4 2017 | $502,000 | +6.4% | 9,026 | -13.3% | 0.01% | 0.0% |
| Q3 2017 | $472,000 | +72.9% | 10,409 | +28.3% | 0.01% | +100.0% |
| Q2 2017 | $273,000 | – | 8,112 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 1,195,000 | $142,432,000 | 6.16% |
| Casdin Capital, LLC | 305,000 | $36,353,000 | 3.99% |
| Eventide Asset Management | 845,168 | $100,736,000 | 3.47% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 436,000 | $51,967,000 | 3.26% |
| NEXTHERA CAPITAL LP | 21,270 | $2,535,000 | 3.08% |
| Camber Capital Management LP | 500,000 | $59,595,000 | 2.97% |
| Eversept Partners, LP | 83,574 | $9,961,185 | 2.91% |
| CADIAN CAPITAL MANAGEMENT, LP | 610,546 | $72,771,000 | 2.84% |
| RTW INVESTMENTS, LP | 338,199 | $40,310,000 | 2.75% |
| Cormorant Asset Management, LP | 300,000 | $35,757,000 | 2.42% |